IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.

TitleIFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.
Publication TypeJournal Article
Year of Publication2017
AuthorsRaposo R.A.
JournalJCI Insight
Volume2
Issue1